Taconic Advances Preclinical Models for Parkinson’s Research
Parkinson’s disease affects millions worldwide, yet progress toward better diagnostics and treatments remains slow, due to the complexity of the disease and limitations in current research models. Taconic Biosciences is helping to change that. By providing high-quality, reproducible preclinical models, Taconic supports researchers working to uncover early biomarkers, explore disease progression, and develop more effective, personalized therapies. Their reliable animal models are designed to address key challenges in Parkinson’s research, helping scientists move closer to breakthroughs in both understanding and treating this multifactorial disease.
Taconic Advances Preclinical Models for Parkinson’s Research